These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37533175)

  • 1. Genetic variants of dipeptidyl peptidase IV are linked to the clinicopathologic development of prostate cancer.
    Wen YC; Lin CY; Hsiao CH; Wang SS; Huang HC; Lin YW; Ho KH; Chang LC; Yang SF; Chien MH
    J Cell Mol Med; 2023 Sep; 27(17):2507-2516. PubMed ID: 37533175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of dipeptidyl peptidase IV polymorphism with clinicopathological characters of oral cancer.
    Chen PJ; Lu HJ; Nassef Y; Lin CW; Chuang CY; Lee CY; Chiu YW; Yang SF; Yang WE
    J Oral Pathol Med; 2022 Sep; 51(8):730-737. PubMed ID: 35880802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DPP4 genetic variants influence baseline prostate-specific antigen levels: the J-MICC study.
    Higashibata T; Naito M; Mori A; Ozawa N; Furuta M; Tsuchiya R; Koyama E; Morita E; Kawai S; Okada R; Yin G; Wakai K; Hamajima N
    Nagoya J Med Sci; 2013 Feb; 75(1-2):73-80. PubMed ID: 23544270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional variants of the chitinase 3-like 1 gene are associated with clinicopathologic outcomes and progression of prostate cancer.
    Wen YC; Lin CY; Ho KH; Lin YW; Hsiao CH; Wang SS; Chang LC; Yang SF; Chien MH
    J Cell Mol Med; 2023 Dec; 27(24):4202-4214. PubMed ID: 37902124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of DPP4 Gene Polymorphisms with Type 2 Diabetes Mellitus in Malaysian Subjects.
    Ahmed RH; Huri HZ; Al-Hamodi Z; Salem SD; Al-Absi B; Muniandy S
    PLoS One; 2016; 11(4):e0154369. PubMed ID: 27111895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MAOB expression correlates with a favourable prognosis in prostate cancer, and its genetic variants are associated with the metastasis of the disease.
    Huang HC; Hsieh YH; Hsiao CH; Lin CY; Wang SS; Ho KH; Chang LC; Huang HM; Yang SF; Chien MH
    J Cell Mol Med; 2024 Apr; 28(8):e18229. PubMed ID: 38520217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of dipeptidyl peptidase IV polymorphism, serum lipid profile, and coronary artery stenosis in patients with coronary artery disease and type 2 diabetes.
    Wang Z; Liu Y; Wang W; Qu H; Han Y; Hou Y
    Medicine (Baltimore); 2021 Apr; 100(13):e25209. PubMed ID: 33787603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic characterization of primary and metastatic prostate cancer reveals reduced proteinase activity in aggressive tumors.
    Li QK; Chen J; Hu Y; Höti N; Lih TM; Thomas SN; Chen L; Roy S; Meeker A; Shah P; Chen L; Bova GS; Zhang B; Zhang H
    Sci Rep; 2021 Sep; 11(1):18936. PubMed ID: 34556748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer Stem Cell Gene Variants in CD44 Predict Outcome in Stage II and Stage III Colon Cancer Patients.
    Stotz M; Herzog SA; Pichler M; Smolle M; Riedl J; Rossmann C; Bezan A; Stöger H; Renner W; Berghold A; Gerger A
    Anticancer Res; 2017 Apr; 37(4):2011-2018. PubMed ID: 28373475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between CXCL10 and DPP4 Gene Polymorphisms and a Complementary Role for Unfavorable IL28B Genotype in Prediction of Treatment Response in Thai Patients with Chronic Hepatitis C Virus Infection.
    Thanapirom K; Suksawatamnuay S; Sukeepaisarnjaroen W; Tangkijvanich P; Treeprasertsuk S; Thaimai P; Wasitthankasem R; Poovorawan Y; Komolmit P
    PLoS One; 2015; 10(9):e0137365. PubMed ID: 26339796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms in dipeptidyl peptidase IV gene are associated with the risk of myocardial infarction in patients with atherosclerosis.
    Aghili N; Devaney JM; Alderman LO; Zukowska Z; Epstein SE; Burnett MS
    Neuropeptides; 2012 Dec; 46(6):367-71. PubMed ID: 23122333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dipeptidyl Peptidase-4 Stabilizes Integrin α4β1 Complex to Promote Thyroid Cancer Cell Metastasis by Activating Transforming Growth Factor-Beta Signaling Pathway.
    He Q; Cao H; Zhao Y; Chen P; Wang N; Li W; Cui R; Hou P; Zhang X; Ji M
    Thyroid; 2022 Nov; 32(11):1411-1422. PubMed ID: 36166219
    [No Abstract]   [Full Text] [Related]  

  • 13. Association between DPP4 gene polymorphism and serum lipid levels in Chinese type 2 diabetes individuals.
    Xing X; Han Y; Zhou X; Zhang B; Li Y; Wang Z; Liao L; Su L
    Neuropeptides; 2016 Dec; 60():1-6. PubMed ID: 27585937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dipeptidylpeptidase-4 levels and DPP4 gene polymorphisms in patients with COVID-19. Association with disease and with severity.
    Posadas-Sánchez R; Sánchez-Muñoz F; Guzmán-Martín CA; Hernández-Díaz Couder A; Rojas-Velasco G; Fragoso JM; Vargas-Alarcón G
    Life Sci; 2021 Jul; 276():119410. PubMed ID: 33774023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dipeptidyl Peptidase 4 Inhibitors Reduce Hepatocellular Carcinoma by Activating Lymphocyte Chemotaxis in Mice.
    Nishina S; Yamauchi A; Kawaguchi T; Kaku K; Goto M; Sasaki K; Hara Y; Tomiyama Y; Kuribayashi F; Torimura T; Hino K
    Cell Mol Gastroenterol Hepatol; 2019; 7(1):115-134. PubMed ID: 30510994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dipeptidyl Peptidase IV as a Prognostic Marker and Therapeutic Target in Papillary Thyroid Carcinoma.
    Lee JJ; Wang TY; Liu CL; Chien MN; Chen MJ; Hsu YC; Leung CH; Cheng SP
    J Clin Endocrinol Metab; 2017 Aug; 102(8):2930-2940. PubMed ID: 28575350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A haplotype in the dipeptidyl peptidase 4 gene impacts glycemic-related traits of Brazilian older adults.
    Alves ES; Tonet-Furioso AC; Alves VP; Moraes CF; Pérez DIV; Bastos IMD; Córdova C; Nóbrega OT
    Braz J Med Biol Res; 2022; 55():e12148. PubMed ID: 36197412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD26/DPP4 - a potential biomarker and target for cancer therapy.
    Enz N; Vliegen G; De Meester I; Jungraithmayr W
    Pharmacol Ther; 2019 Jun; 198():135-159. PubMed ID: 30822465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The rs12617336 and rs17574 Dipeptidyl Peptidase-4 Polymorphisms Are Associated With Hypoalphalipoproteinemia and Dipeptidyl Peptidase-4 Serum Levels: A Case-Control Study of the Genetics of Atherosclerotic Disease (GEA) Cohort.
    Vargas-Alarcón G; González-Salazar MDC; Vázquez-Vázquez C; Hernández-Díaz Couder A; Sánchez-Muñoz F; Reyes-Barrera J; Criales-Vera SA; Sánchez-Guerra M; Osorio-Yáñez C; Posadas-Sánchez R
    Front Genet; 2021; 12():592646. PubMed ID: 34178021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of circulating dipeptidyl peptidase 4 activity in patients with metastatic prostate cancer.
    Nazarian A; Lawlor K; Yi SS; Philip J; Ghosh M; Yaneva M; Villanueva J; Saghatelian A; Assel M; Vickers AJ; Eastham JA; Scher HI; Carver BS; Lilja H; Tempst P
    Mol Cell Proteomics; 2014 Nov; 13(11):3082-96. PubMed ID: 25056937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.